New bladder cancer drug combo shows promise in early trial
NCT ID NCT07445308
First seen Mar 11, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tests a new drug called SPGL008, given alone or with a standard therapy (BCG), for people with a type of bladder cancer that hasn't spread into the muscle wall. The main goals are to find the safest dose and see if the drug helps control the cancer. About 120 adults who cannot or choose not to have their bladder removed will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NMIBC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.